NCT06926946View on ClinicalTrials.gov

SafeBoosC-IIIv - Does Cerebral Oximetry Monitoring Affect Renal Outcomes

NANot yet recruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

June 1, 2027

Study Completion Date

September 15, 2027

Conditions
Acute Renal FailureNeonatal Morbidity
Interventions
OTHER

Intervention Arm- Cerebral Oximetry + Treatment Guideline

if the cerebral oximeter shows low values, a pre designed treatment guideline will be followed and corrective actions taken.

Trial Locations (1)

560034

St. jOhn's Medical college & Hospital, Bengaluru

All Listed Sponsors
collaborator

Rigshospitalet, Denmark

OTHER

lead

St. John's Research Institute

OTHER

NCT06926946 - SafeBoosC-IIIv - Does Cerebral Oximetry Monitoring Affect Renal Outcomes | Biotech Hunter | Biotech Hunter